Abstract
This case discusses a pharmacokinetic drug interaction between buprenorphine, ritonavir, and atazanavir. Buprenorphine is a cytochrome P450 3A4 substrate. Ritonavir and atazanavir are both potent 3A4 inhibitors.
Original language | English (US) |
---|---|
Title of host publication | A Case Approach to Perioperative Drug-Drug Interactions |
Publisher | Springer New York |
Pages | 245-247 |
Number of pages | 3 |
ISBN (Print) | 9781461474951, 9781461474944 |
DOIs | |
State | Published - Sep 15 2015 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
A needle and the damage done : Fatal forty DDI: Buprenorphine, ritonavir, CYP3A4. / Hilliard, James; Lalwani, Kirk.
A Case Approach to Perioperative Drug-Drug Interactions. Springer New York, 2015. p. 245-247.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - A needle and the damage done
T2 - Fatal forty DDI: Buprenorphine, ritonavir, CYP3A4
AU - Hilliard, James
AU - Lalwani, Kirk
PY - 2015/9/15
Y1 - 2015/9/15
N2 - This case discusses a pharmacokinetic drug interaction between buprenorphine, ritonavir, and atazanavir. Buprenorphine is a cytochrome P450 3A4 substrate. Ritonavir and atazanavir are both potent 3A4 inhibitors.
AB - This case discusses a pharmacokinetic drug interaction between buprenorphine, ritonavir, and atazanavir. Buprenorphine is a cytochrome P450 3A4 substrate. Ritonavir and atazanavir are both potent 3A4 inhibitors.
UR - http://www.scopus.com/inward/record.url?scp=84955355015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955355015&partnerID=8YFLogxK
U2 - 10.1007/978-1-4614-7495-1_50
DO - 10.1007/978-1-4614-7495-1_50
M3 - Chapter
AN - SCOPUS:84955355015
SN - 9781461474951
SN - 9781461474944
SP - 245
EP - 247
BT - A Case Approach to Perioperative Drug-Drug Interactions
PB - Springer New York
ER -